Lexaria Bioscience announces 1-for-15 reverse stock split effective Aug 3, 2026 to regain Nasdaq compliance

Lexaria Bioscience Corp.

Reverse split ratio 1-for-15; effective 12:01 a.m. ET on August 3, 2026.
Outstanding shares reduced from ~24.8M to ~1.65M; authorized shares cut from 220M to 14.7M.
Primary goal: regain Nasdaq minimum $1.00 bid price compliance under Listing Rule 5550(a)(2).
No fractional shares issued; fractional shares rounded up to whole shares.
Stock symbol LEXX unchanged; new CUSIP 52886N604.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.